awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35632548-11DADF06-DF6A-4A31-8C0F-2EB98C3E085A
Q35632548-11DADF06-DF6A-4A31-8C0F-2EB98C3E085A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35632548-11DADF06-DF6A-4A31-8C0F-2EB98C3E085A
Progression-free Survival Decreases with Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials.
P2860
Q35632548-11DADF06-DF6A-4A31-8C0F-2EB98C3E085A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35632548-11DADF06-DF6A-4A31-8C0F-2EB98C3E085A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4c2a9fe45b531c2e4753173603db685a9aa0760b
P2860
Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study).